Hye Y. Kim
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
A small molecule modulating heterogeneous amyloid-β isoforms improves cognitive and pathological outcomes in acute and 5XFAD Alzheimer's disease models.
Journal: Alzheimer's research & therapy
Published: February 23, 2026
YIAD-0501 directly dissociates aggregates of full-length and N-terminal pyroglutamate-modified forms of Aβ.
Journal: Alzheimer's research & therapy
Published: December 26, 2025
Temporal and regional trends in the diagnosis and treatment of spontaneous intracranial hypotension: a systematic review.
Journal: The journal of headache and pain
Published: November 23, 2025
Small Molecule Therapeutics Targeting Amyloid-β in Alzheimer's Disease: Mechanisms, Clinical Progress, and Future Strategies.
Journal: Experimental neurobiology
Published: October 24, 2025
Tau Repeats Disassemble Amyloid-β Fibrils In Vitro by Interacting with KLVFFA and GGVVIA Domains.
Journal: ACS chemical neuroscience
Published: April 14, 2025
Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls.
Journal: Experimental neurobiology
Published: February 20, 2025
Drug Discovery and Screening Tool Development for Tauopathies by Focusing on Pathogenic Tau Repeat 3 Oligomers.
Journal: Angewandte Chemie (International ed. in English)
Published: June 25, 2024
Chemically Driven Clearance of Amyloid Aggregates by Polyfunctionalized Furo[2,3-b:4,5-b']dipyridine-Chalcone Hybrids to Ameliorate Memory in an Alzheimer Mouse Model.
Journal: Molecular pharmaceutics
Published: June 14, 2024
Comparison of the pharmacokinetic characteristics and bioequivalence between two nanosuspension formulations of megestrol acetate in healthy Korean male subjects.
Journal: Translational and clinical pharmacology
Published: March 14, 2024
Modulation of Amyloid and Tau Aggregation to Alleviate Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease.
Journal: ACS pharmacology & translational science
Published: January 08, 2024
Last Updated: 09/26/2026